Print
Email
Print Edition StoriesThursday, September 17, 2009
UMass scores $47M in stimulus funds, $73M in licensing income
By Brendan Lynch
MHT's Julie Donnelly: Life science startups finding investments
MHT's Efrain Viscarolasaga: Tech companies may have to wait for stimulus funds
MHT managing editor Rodney Brown on NECN: 22 tech companies give back to community
The University of Massachusetts has brought in $47 million in grants under the American Recovery and Reinvestment Act, and its licensing income from the school’s intellectual property shot to $73 million for Fiscal 2009.
The licensing amount is an all-time high for the five-school system, according to the UMass president’s office. Of the $73 million, $30 million was an upfront payment from the licensing of a human monoclonal antibody combination for clostridium difficile infection — a treatment developed at the UMass Medical School’s Massachusetts Biologic Laboratories.
In Fiscal 2008 the UMass system generated $37 million in licensing fees from its intellectual property.
More than 400 research proposals for stimulus money have been submitted from researchers at the five UMass campuses, according to the president’s office. The $47 million comprises 65 proposals that have been approved.
UMass Amherst professor Thomas Russell received $16 million to fund his research on improving the performance of polymer materials in converting sunlight into electricity. UMass Medical School professor Robert Finberg got $3.7 million for a project that focuses on improving the fundamental understanding of the herpes simplex 1 virus, the immunity response of hosts and factors relating to the dormancy and reactivation of the disease in humans.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
